Trimi vs bmiMD: Compounded GLP-1 Pricing and Policies
The Trimi vs bmiMD comparison focuses on pricing model, medication type, shipping, refund policies, and clinician oversight. Early verdict: choose Trimi if you prioritize a low advertised semaglutide starting price, flat per-dose pricing and a 6-month money-back promise; choose bmiMD if you prefer tiered tirzepatide plans with lower long-term monthly equivalents and 24/7 clinician access.
Head-to-head summary: Trimi vs bmiMD
Both offer compounded GLP-1/GIP options shipped to your door and state-licensed pharmacies, but they differ on drug focus, pricing structure, refunds and clinician access. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Key differences to weigh
1. Medication focus and types
Trimi highlights compounded semaglutide and tirzepatide with explicit semaglutide pricing from $99/mo and tirzepatide at $125/month on annual plans. bmiMD emphasizes compounded tirzepatide (GLP-1/GIP) with multi-month subscription options and the lowest monthly equivalent on a 12-month plan.
2. Pricing model and commitments
Trimi advertises flat pricing that never rises as dose increases and lists semaglutide from $99/mo on annual plans and tirzepatide $125/month. bmiMD offers multiple billing options: $179 month-to-month, $159 for three months, $149 for six months, and $139 for the 12-month plan, with the lowest price requiring a 12-month commitment.
3. Shipping and delivery
Both vendors advertise free shipping. Trimi specifies free overnight, temperature-controlled shipping. bmiMD advertises free subscription shipping on every order.
4. Refunds and eligibility
Trimi states: “Not approved by our medical team? 100% automatic refund” and backs a 6-month money-back promise with terms that apply. bmiMD advertises “100% Risk Free. 100% Refundable if not eligible for program.” Both emphasize confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.
5. Clinical oversight and pharmacy handling
Trimi notes prescriptions are provided by US-licensed clinicians through Arora Health and compounded by state-licensed 503A pharmacies, with named pharmacies and certificates of analysis available on request. bmiMD states medications are prepared in state-licensed pharmacies and independently verified in FDA- and DEA-registered labs, with clinician review required for treatment.
Quick comparison table
| Criteria | Trimi | bmiMD |
|---|---|---|
| Primary drug | Semaglutide and tirzepatide (compounded) | Tirzepatide (compounded GLP-1/GIP) |
| Starting price | Semaglutide from $99/mo; tirzepatide $125/mo (annual) | $179/mo month-to-month; $139/mo on 12-month plan |
| Pricing structure | Flat pricing that never rises as dose increases | Multi-month tiers; lowest price requires 12-month commitment |
| Shipping | Free overnight, temperature-controlled shipping | Free subscription shipping on every order |
| Refunds | Not approved? 100% automatic refund; 6-month money-back promise (terms apply) | 100% refundable if not eligible; “100% Risk Free” claim |
| Clinical/pharmacy notes | Prescribed by US-licensed clinicians via Arora Health; state-licensed 503A pharmacies named; COA on request | Prepared in state-licensed pharmacies, verified in FDA- and DEA-registered labs; clinician review required |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | |
How each provider presents access and care
Trimi emphasizes a national clinical network led by a named medical director and licensed providers who review plans, with a focus on evidence from peer-reviewed trials behind the active ingredients. bmiMD highlights clinician-reviewed online treatment with 24/7 clinician access and online refills and delivery.
Choosing between them
Trimi vs bmiMD centers on tradeoffs between headline price and commitment structure. Trimi advertises the lower semaglutide starting price and flat per-dose pricing plus a 6-month money-back promise and overnight shipping. bmiMD advertises flexible billing with a lower long-term monthly equivalent on multi-month plans and continuous clinician access.
Review bmiMD tirzepatide options
Conclusion: Trimi vs bmiMD
Trimi vs bmiMD is a comparison of lower advertised semaglutide list price and flat-dose pricing with rapid shipping and a 6-month money-back promise (Trimi) against tiered tirzepatide subscriptions, lower long-term monthly equivalents, and 24/7 clinician access (bmiMD). Compounded medications from both providers are not FDA-approved.
Choose Trimi if…
- You want compounded semaglutide advertised from $99/mo, flat pricing that does not increase as dose changes, free overnight shipping, and a 6-month money-back promise (terms apply).
- You value named compounding pharmacies, clinician oversight via Arora Health, and certificates of analysis available on request.
Choose bmiMD if…
- You are comparing tirzepatide subscription tiers and prefer the lower monthly equivalent on a 12-month plan ($139/mo) and 24/7 clinician access, with free subscription shipping.
- You accept that the lowest price requires a longer commitment and that compounded medications are not FDA-approved.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
